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Abstract: Nicholas reactions on 2,7-dioxygenated naphthalenes 
give C-1 monosubstitution and C-1/C-8 disubstitution in most 
cases. From γ- carbonyl cation monocondensation product 3b or 
alkyne- unsubstituted dicondensation product 4a, cyclo-
hepta[de]naphthalenes bearing no substituents, gem- dimethyl 
substituents, and a ketone function, and the rearranged abietane 
framework of microstegiol may be prepared.  
Key words: Carbocations, alkyne complexes, transition metals, 
electrophilic aromatic substitution, ring closure, tautomerism. 
We have a long standing interest in the synthesis of sev-
en membered ring systems, particularly involving the 
chemistry of alkyne dicobalt complexes and propar-
gyldicobalt cations.1,2 In particular, we have developed 
chemistry to incorporate nucleophiles, including electron 
rich arenes, γ- to electron withdrawing groups,3 in an 
umpolung fashion,4-6 and have used this chemistry to get 
access to seven membered ring systems.1a  
In this context we were drawn to cyclo-
hepta[de]naphthalenes, featured in the rearranged abi-
etanes such as microstegiol7 and salvibretol,8 and their 
oxygenated analogues (Figure 1).8,9 These compounds 
are isolated from a number of plants of the salvia species 
that have long seen use as folk remedies and whose 
crude extracts have demonstrated antibacterial and anti-
cancer activities;10 microstegiol itself is known to pos-
sess antileukemic activity7,11 and modest antibacterial 
activity.10b Surprisingly, these compounds have not re-
ceived synthetic attention. Therefore we considered it 
worthy goal to investigate our Nicholas reaction- and γ-
carbonyl cation chemistry towards the construction of 
the cyclohepta[de]naphthalene nucleus, with a particular 
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Figure 1 Rearranged abietanes containing cyclohepta[de]naphthalene 
nucleus. 
As a starting point to test reactivity, 2,7-
dimethoxynaphthalene (1) was chosen, by virtue of its 
ready availability, its ability to direct monosubstitution to 
C-1 over C-3 in most cases12 and disubstitution to C-
1/C-8 over C-1/C-6 in many cases, and the potential for 
one alkoxy to serve as the masked version of the ketone 
function in microstegiol or salvibretol. Compound 1 
showed sufficient nucleophilicity to react with propar-
gyldicobalt cations; propargyl alcohol complex 2a un-
derwent BF3-OEt2 mediated reaction to give 3a in excel-
lent yield (93%) (Table 1). Use of γ- carbonyl cation 
precursor 2b (R1 = CO2Me) gave good yields of conden-
sation product 3b (76%), while substitution on the re-
mote alkyne carbon with methyl (2c) and trimethylsilyl 
(2d) functions also allowed formation of condensation 
products (3c-d) successfully (3c, 84%; 3d, 71%).13 Poly-
alkylation of the naphthalene nucleus did not appear to 
be a significant problem.14 













Complex R1 Product Yield (%) 
2a H 3a 93 
2b CO2Mea 3b 76 
2c Me 3c 84 
2d SiMe3b 3d 71 
a
 Compound 2b was employed as the methyl ether 
b
 Reaction conducted at 0 oC – RT. 
Disubstitution reactions on 1 could also be accom-
plished, by increasing the amount of propargyldicobalt 
cation precursors (2) to 2.2 equiv. For these reactions, 
the predominant 1,8-disubstitution pattern (4) was ob-
served only for the unsubstituted (R1 = H) and electron 
withdrawing group substituted (R1 = CO2Me) propargyl 
cation complex precursors 2a and 2b (Table 2).15 In the 
case of other R1 substituents (R1 = Me, Me3Si), the sec-
ond substitution occurred at C-6, giving 5c and 5d. In the 
case of 2d (R1 = Me3Si), the second condensation was 
somewhat sluggish, and substantial amounts of 3d were 
isolated in addition to 5d despite allowing the reaction to 
warm to room temperature. 
Table 2 Dicondensation reactions of 1 
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Complex R1 Product Yield (4,5) (%) 
2a H 4a, 5a 69, 9 
2b CO2Mea 4b 86, 0 
2c Me 5c 0, 86 
2d SiMe3 3d, 5d 0, 40b 
 
   
a
 Compound 2b was employed as the methyl ether 
b
 Reaction conducted at 0 oC – RT. In addition, 59 % of 3d was iso-
lated. 
Given a basic understanding of the reactivity of 2,7-
dioxygenated naphthalenes to propargyldicobalt cations, 
we considered γ-carbonyl cation adduct  3b and 1,8- 
dicondensation product 4a viable intermediates in the 
synthesis of cyclohepta[de]naphthalenes, and this possi-
bility was explored. The unsubstituted cyclo-
hepta[de]naphthalene nucleus was approached beginning 
with 4a (Scheme 1). Decomplexation of the alkyne func-
tions could be effected by (NH4)2Ce(NO3)6, affording 
diyne 6 in 57% yield (64% based on recovered starting 
4a). Hydrogenation of the alkynes using the Lindlar 
catalyst gave the diallylated naphthalene 7 (90% yield), 
and subsequent ring closing metathesis using 
(Cy3P)2Cl2Ru=CHPh (Grubbs 1 catalyst, 5 mol%) af-
forded 8 in 77% yield.16 After the viability of this ap-
proach had been demonstrated, it was reported that the 
corresponding diacetoxy compound also has been pre-
pared by ring closing metathesis chemistry.17 
OMeMeO4a
OMeMeO OMeMeO
6, 57% (66% brsm)
7, 90% 8, 77%
(NH4)2Ce(NO2)6
acetone,





Grubbs I, 5 mol%
CH2Cl2, 12 h, 0 oC - RT
 
Scheme 1 Dihydrocyclohepta[de]naphthalene preparation from 4a via 
ring closing metathesis.  
As opposed to 8, other cyclohepta[de]naphthalene model 
systems were best approached from 3b. For dimethyl 
substituted cyclohepta[de]naphthalene 9, 3b was readily 
decomplexed by I2 in THF to give 10 in excellent yield 
(98%) (Scheme 2). Catalytic hydrogenation of the alkyne 
function was sluggish over Pd/C, but proceeded well 
over Rh/C to afford 11 (99% yield). Subsequent addition 
of excess MeLi to the ester gave tertiary alcohol 13 (61% 
yield) along with an amount of methyl ketone 12 (25% 
yield). Finally, treatment of tertiary alcohol 13 with 
H2SO4 (1 drop) gave cyclohepta[de]naphthalene 9 (70% 
yield), contaminated with a small amount (10%) of elim-












9, 70% 14, 10%
12 , 25% 13, 61%








Et2O, -78 oC - RT
H2SO4, CH2Cl2
0 oC - RT, 12 h
 
Scheme 2 Conversion of 3b to 7,7-
dimethyltetrahydrocyclohepta[de]naphthalene. 
Similarly, cyclohepta[de]naphthalenone 15 was best 
approached via a monocondensation route employing γ-
carbonyl cation precursor 2b. In this case, unsymmetri-
cally substituted 16, bearing a more readily deprotected 
acetate function, was chosen as the starting point 
(Scheme 3). Lewis acid mediated (either BF3-OEt2 
(88%)
 
or Bu2BOTf (90%)) reaction of 16 with propargyl 
methyl ether complex 2b gave monocondensation prod-
uct 17 in excellent yield. After removal of the hexacar-
bonyldicobalt unit (I2, THF, 93%) to give 18, catalytic 
hydrogenation (H2, Pd/C) of the alkyne function afforded 
19 (94%). Hydrolysis of both the methyl ester and ace-
tate functions was rather sluggish, but in K2CO3/MeOH 
at reflux, 19 gradually was converted to phenolic acid 20 
(76%). Subjecting 20 to polyphosphoric acid (CH2Cl2, 
reflux, 12h) then resulted in closure of the seven- mem-
bered ring to give 15 in good yield (80%).19 The pheno-
lic ring of compound 15 existed entirely in the eno-
lic/phenolic tautomer, as expected based on the existence 
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Scheme 3 Preparation of tetrahydrocyclohepta[de]naphthalene-7-one. 
Finally, we deemed it important to determine whether 
the combination of the seven- membered ring system and 
latent carbonyl function would be sufficient to drive the 
naphthol ring tautomer to the keto form. To this end, 
decomplexed and reduced adduct 19 was subjected to 
reaction with MeLi, affording tertiary alcohol 21 in 70% 
yield (Scheme 4). Exposure of 21 to a single drop of 
H2SO4 in CH2Cl2 promoted rapid cyclization at 0 oC, 
giving 22 in 70% yield. Compound 22 existed entirely in 
the dehydro- β-tetralone tautomeric structure present in 
microstegiol; no evidence of the enol tautomer could be 
observed spectroscopically.21 To our knowledge, this 















Scheme 4 Preparation of rearranged abietane framework of microste-
giol. 
In conclusion, we have demonstrated the viability of 
Nicholas reaction chemistry in the assembly of cyclo-
hepta[de]naphthalene rings, and in the construction of 
the rearranged abietane framework of microstegiol. Fu-
ture work, which involves installation of the γ- carbonyl 
cation equivalent ortho- to a less donating (methyl) sub-
stituent, and introduction of a hydroxyl function α- to the 
keto function, is in progress and will be reported in due 
course. 
Experimental Section  
To a solution of 2,7-dimethoxynaphthalene 1 in CH2Cl2 
(0.05 M) at 0 oC was added propargyl alcohol complex 2 
(1.1 equiv for monocondensations, 2.2 equiv for dicon-
densations) and BF3-OEt2 (3 equiv). After 3 h of stirring 
at 0 oC, NH4Cl(aq) was added, and the mixture subjected 
to a conventional extractive workup. Purification by 
flash chromatography afforded 3 (monocondensation) or 
4/5 (dicondensation). 
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(M+) 312.0998, found 312.0991. (19) IR (KBr)  υmax 3067, 
2950, 1759, 1734; 1H NMR δ 7.75 (d, J = 8.8, 1H), 7.67 (d, 
J = 1.9, 1H), 7.65 (d, J = 9.0, 1H), 7.16 (d, J = 9.0, 1H), 
7.09 (dd, J = 8.8, 1.9, 1H), 3.85 (s, 3H), 3.64 (s, 3H), 3.08 
(t, J = 17.6, 2H), 2.39 (t, J = 7.4, 2H), 2.33 (s, 3H), 1.99 (m, 
2H); 13C NMR 173.9, 169.5, 154.9, 149.1, 133.6, 129.9, 
127.6, 127.1, 122.3, 118.4, 114.0, 112.7, 56.1, 51.2, 33.5, 
24.7, 24.0, 21.1; MS m/e 316 (M+); HRMS m/e for 
C18H20O5 calcd (M+) 316.1311, found 316.1316. (20) . IR 
(KBr)  υmax 3385 br, 2924, 1703, 1626; 1H NMR (acetone-
d6) δ 7.63 (d, J = 8.8, 1H), 7.62 (d, J = 9.0, 1H), 7.28 (br 
s,1H), 7.11 (d, J = 9.0, 1H), 6.93 (dd, J = 8.8, 2.1, 1H), 3.87 
(s, 3H), 2.99 (t, J = 7.7, 2H), 2.35 (m, 2H), 1.85 (m, 2H); 
13C NMR (acetone-d6) 174.5, 156.0, 155.1, 134.8, 130.2, 
127.7, 124.5, 120.7, 115.7, 110.3, 104.8, 55.8, 33.3, 24.8, 
24.1; MS m/e 260 (M+); HRMS m/e for C15H16O4 calcd 
(M+) 260.1049, found 260.1045. (15) IR (KBr)  λmax 3009, 
2970, 1616 cm-1; 1H NMR δ 12.73 (s, 1H), 7.71 (d, J = 8.9, 
1H), 7.63 (d, J = 8.8, 1H), 7.12 (d, J = 8.8, 1H), 6.93 (d, J = 
8.9, 1H), 3.95 (s, 3H), 3.01 (t, J = 7.1, 2H), 2.71 (t, J = 7.4, 
2H), 2.39 (m, 2H); 13C NMR 207.4, 162.5, 157.3, 136.2, 
135.7, 128.6, 123.2, 122.3, 116.5, 115.2, 110.3, 56.2, 42.3, 
29.5, 25.4; MS m/e 242 (M+); HRMS for C15H14O3 calcd 
(M+) 242.0943, found 242.0931. 
(20) a) Rieche, A.; Fruhwald, E. Chem. Ber. 1931, 64B, 1603.; 
b) Moghaddam, F. M.; Porkaleh, H.; Zali-Boeini, H. Lett. 
Org. Chem. 2006, 3, 123. 
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(21) (21) IR (KBr) υmax 3358, 2967 cm-1; 1H NMR δ 8.10 (br s, 
1H), 7.65 (d, J = 8.8, 1H), 7.61 (d, J = 8.9, 1H), 7.33 (d, J = 
2.2, 1H), 7.08 (d, J = 8.9, 1H), 7.01 (dd, J = 8.8, 2.2, 1 H), 
3.91 (s, 3H), 2.95 (br t, J = 7.0, 2H), 2.60 (br s, 1H), 1.65 
(m, 4H), 1.21 (s, 6H); 13C NMR 154.6, 154.5, 134.4, 130.3, 
127.3, 124.5, 122.1, 115.6, 110.7, 105.3, 72.0, 56.4, 43.5, 
29.1, 25.4, 24.3; MS m/e 274 (M+); HRMS m/e for 
C17H22O3 calcd 274.1569, found 274.1574. (22) IR (KBr) 
υmax 2934, 1653, 1615 cm-1; 1H NMR δ 7.29 (d, J = 9.7, 
1H), 7.13 (d, J = 8.4, 1H), 6.79 (d, J = 8.4, 1H), 5.97 (d, J = 
9.7, 1H), 3.84 (s, 3H), 3.63 (s, 1H), 3.36 (m, 1H), 2.42 (m, 
1H), 1.84 (m, 1H), 1.51 (m, 1H), 1.38 (m, 1H), 1.27 (m, 
1H), 1.17 (s, 3H), 0.66 (s, 3H); 13C NMR 203.2, 157.7, 
145.5, 140.8, 129.4, 127.9, 124.4, 123.5, 108.9, 58.3, 55.7, 
43.2, 37.0, 27.4, 24.2, 21.5, 20.2; MS m/e 256 (M+); 
HRMS m/e for C17H20O2 calcd 256.1463, found 256.1457.
6 LETTER  
Template for SYNLETT and SYNTHESIS © Thieme  Stuttgart · New York 2012-11-29 page 6 of 6 
 
